Elanco Animal Health Incorporated (ELAN)

13,53 +0,06 (+0,45%) Alla chiusura: 04:00PM EDT

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
https://www.elanco.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 9.300

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Jeffrey N. Simmons	President, CEO & Director	2,46M	N/D	1967
Mr. Todd S. Young J.D.	Executive VP & CFO	1,11M	N/D	1972
Dr. Ramiro Martin Cabral	Executive Vice President of Elanco International	950,74k	N/D	1972
Dr. Ellen de Brabander Ph.D.	Executive Vice President of Innovation, Regulatory & Business Development	1,14M	N/D	1963
Mr. Timothy J. Bettington	Executive Vice President of Corporate Strategy & Market Development	1,19M	N/D	1974
Mr. James M. Meer	Senior VP & Chief Accounting Officer	N/D	N/D	1970
Mr. Chris Keeley	Senior VP & Chief Information Officer	N/D	N/D	N/D
Mr. David S. Kinard	Executive Vice President of Human Resources, Corporate Communications & Administration	722,58k	N/D	1967
Katy Grissom	Head of Investor Relations	N/D	N/D	N/D
Ms. Shiv O'Neill	Executive Vice President, General Counsel & Corporate Secretary	N/D	N/D	1974

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Governance aziendale

L'ISS Governance QualityScore di Elanco Animal Health Incorporated al 1 maggio 2024 è 7. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 8; diritti degli azionisti: 7; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.